Progyny (PGNY) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Progyny (PGNY) stock.

Analyst Consensus — 13 Analysts

2S.Buy

11Buy

# Analysts13

Latest Upgrades and Downgrades for Progyny Stock

Date	Firm	Analyst	Action	Rating Change	Price Target
—	JP Morgan	Lisa Gill	PT Raise	Neutral	$30→$35
—	Leerink Partners	Michael Cherny	PT Raise	Outperform	$37→$38
—	Wells Fargo	Stan Berenshteyn	PT Raise	Overweight	$37→$38
—	Citizens	Constantine Davides	PT Raise	Market Outperform	$33→$38
—	Cantor Fitzgerald	Sarah James	PT Raise	Overweight	$31→$35
—	Wells Fargo	Stan Berenshteyn	Initiate	Overweight	$37
—	Citizens	Constantine Davides	PT Raise	Market Outperform	$31→$33
—	JP Morgan	Lisa Gill	PT Raise	Neutral	$27→$30
—	Wells Fargo	Stan Berenshteyn	Initiate	Overweight	$37
—	Truist Securities	Jailendra Singh	PT Raise	Buy	$33→$36
—	Barclays	Peter Warendorf	PT Cut	Equal-Weight	$34→$30
—	Barclays	Peter Warendorf	Downgrade	Overweight→Equal-Weight	$27→$34
—	BTIG	David Larsen	PT Raise	Buy	$30→$40
—	Canaccord Genuity	Richard Close	PT Raise	Buy	$30→$36
—	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$30→$35
—	Truist Securities	Jailendra Singh	PT Raise	Buy	$30→$33
—	B of A Securities	Michael Cherny	PT Raise	Buy	$29→$31
—	Canaccord Genuity	Richard Close	Upgrade	Hold→Buy	$19→$30
—	Barclays	Glen Santangelo	PT Raise	Overweight	$23→$27
—	Truist Securities	Jailendra Singh	PT Raise	Buy	$28→$30

Progyny Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Progyny (PGNY) Stock Price Target 2026

Latest Upgrades and Downgrades for Progyny Stock

Progyny (PGNY) Stock Price Target 2026

Latest Upgrades and Downgrades for Progyny Stock

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $35

PRO
Leerink Partners Maintains Outperform on Progyny, Raises Price Target to $38

PRO
Wells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $38

PRO
Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33

People Also Watch

People Also Watch

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $35

PRO
Leerink Partners Maintains Outperform on Progyny, Raises Price Target to $38

PRO
Wells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $38

PRO
Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33

Progyny Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Progyny (PGNY) Stock Price Target 2026

Latest Upgrades and Downgrades for Progyny Stock

Progyny (PGNY) Stock Price Target 2026

Latest Upgrades and Downgrades for Progyny Stock

Analyst Ratings News

PROJP Morgan Maintains Neutral on Progyny, Raises Price Target to $35

PROLeerink Partners Maintains Outperform on Progyny, Raises Price Target to $38

PROWells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

PROCitizens Maintains Market Outperform on Progyny, Raises Price Target to $38

PROCantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35

PROCitizens Maintains Market Outperform on Progyny, Raises Price Target to $33

People Also Watch

People Also Watch

Analyst Ratings News

PROJP Morgan Maintains Neutral on Progyny, Raises Price Target to $35

PROLeerink Partners Maintains Outperform on Progyny, Raises Price Target to $38

PROWells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

PROCitizens Maintains Market Outperform on Progyny, Raises Price Target to $38

PROCantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35

PROCitizens Maintains Market Outperform on Progyny, Raises Price Target to $33

PRO
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $35

PRO
Leerink Partners Maintains Outperform on Progyny, Raises Price Target to $38

PRO
Wells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $38

PRO
Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33

PRO
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $35

PRO
Leerink Partners Maintains Outperform on Progyny, Raises Price Target to $38

PRO
Wells Fargo Maintains Overweight on Progyny, Raises Price Target to $38

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $38

PRO
Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33